Beaudry, F.E.G.; Li, Z.; Borgida, A.; Zorigtbaatar, A.; Wang, X.; Hildebrand, M.; Hamza, O.; Jang, G.H.; Bucur, R.; Dodd, A.;
et al. Molecular Tumor Board-Guided Targeted Treatments for Biliary Tract Cancers in a Publicly Funded Healthcare System. Curr. Oncol. 2025, 32, 80.
https://doi.org/10.3390/curroncol32020080
AMA Style
Beaudry FEG, Li Z, Borgida A, Zorigtbaatar A, Wang X, Hildebrand M, Hamza O, Jang GH, Bucur R, Dodd A,
et al. Molecular Tumor Board-Guided Targeted Treatments for Biliary Tract Cancers in a Publicly Funded Healthcare System. Current Oncology. 2025; 32(2):80.
https://doi.org/10.3390/curroncol32020080
Chicago/Turabian Style
Beaudry, Felix E. G., Zhihao Li, Ayelet Borgida, Anudari Zorigtbaatar, Xin Wang, Maggie Hildebrand, Oumaima Hamza, Gun Ho Jang, Roxana Bucur, Anna Dodd,
and et al. 2025. "Molecular Tumor Board-Guided Targeted Treatments for Biliary Tract Cancers in a Publicly Funded Healthcare System" Current Oncology 32, no. 2: 80.
https://doi.org/10.3390/curroncol32020080
APA Style
Beaudry, F. E. G., Li, Z., Borgida, A., Zorigtbaatar, A., Wang, X., Hildebrand, M., Hamza, O., Jang, G. H., Bucur, R., Dodd, A., Wilson, J., Auer, R. C., Saibil, S., Tsang, E. S., Vogel, A., O’Kane, G. M., Gallinger, S., Knox, J. J., Notta, F.,
... Grant, R. C.
(2025). Molecular Tumor Board-Guided Targeted Treatments for Biliary Tract Cancers in a Publicly Funded Healthcare System. Current Oncology, 32(2), 80.
https://doi.org/10.3390/curroncol32020080
